Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers
Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNo additions or deletions were detected on the page; the study record content and layout appear unchanged.SummaryDifference0.4%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check47 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check61 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the only visible change is removal of the Back to Top control, with no substantive core-content updates.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as a comprehensive list of proteins and antibodies, while removing several terms related to antineoplastic agents and specific location details.SummaryDifference2%

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers
Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.